DEXYCU Retrospective study
ClinicalTrials.gov NCT04290676
Research payments
$111,070
Through program year 2020, $111,070 in research payments was reported against DEXYCU Retrospective study, across 22 payments, paid by EyePoint Pharmaceuticals US, Inc..
- Paid by
- EyePoint Pharmaceuticals US, Inc.
- ClinicalTrials.gov
- NCT04290676
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $111,070 | 22 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Inder Singh Racine, WI Named on 1 payment
- Jason Bacharach Petaluma, CA Named on 1 payment
- Victor Gonzalez McAllen, TX Named on 1 payment
- Sebastian Heersink Dothan, AL Named on 1 payment
- Navin Tekwani Saint Louis, MO Named on 1 payment
- Dan Tran Orange, CA Named on 1 payment
- Robert Weinstock Largo, FL Named on 1 payment
- Nathan Radcliffe New York, NY Named on 1 payment
- Cynthia Matossian Pennington, NJ Named on 1 payment
- Steven Silverstein Kansas City, MO Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.